An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present)
{{output}}
Introduction: Rearranged during transfection (RET) is a receptor tyrosine kinase essential for cell signaling processes such as proliferation, differentiation, and migration. RET alterations, including point mutations and gene fu... ...